Blood vessel smooth muscle contraction pathway

The blood vessel smooth muscle contraction pathway describes the complex signaling mechanisms controlling contraction and relaxation of vascular smooth muscle cells in the vessel wall. Contraction is primarily governed by an increase in intracellular calcium, which activates calmodulin and subsequently myosin light chain kinase (MLCK). Phosphorylation of myosin light chain allows myosin-actin crossbridge formation, resulting in contraction. This calcium influx may be triggered by mechanical (stretch), electrical (depolarization), or chemical (agonist binding to receptors such as alpha-1 adrenergic, angiotensin II type 1, or endothelin-1 receptors) signals, many of which act via G protein-coupled receptor pathways that activate phospholipase C and generate IP₃ and DAG as secondary messengers. Other regulatory pathways include Rho/Rho-kinase dependent calcium sensitization and cAMP/cGMP pathways, the latter of which mediate relaxation. Dysregulation of these contraction pathways underlies a range of cardiovascular disorders, including hypertension, shock, and vasospastic diseases[2][3][4][5][6][7].

Other names

vascular smooth muscle contraction pathwayvascular smooth muscle contraction signalingblood vessel smooth muscle contraction mechanism

Agonism or antagonism of G protein-coupled receptors (e.g., alpha-1 adrenergic receptor agonists/antagonists); Calcium channel blockade; Inhibition of myosin light chain kinase (MLCK) or Rho-kinase; Modulation of intracellular signaling mediators, e.g., cAMP, IP₃/DAG